Science & Technology
MediVet Biologic’s success has been defined by continued innovation which has been allowed by building strong foundations with top research and development teams around the world.
The range of products and services currently available are maintained by the highest standards and allow for patient specific treatment options for a variety of disease states. MediVet’s Biologics goal and mission is to continue to bring novel treatment solutions to the Veterinary market that are based in science and customer support.
MediVet’s flagship referral service is the In-Clinic Adipose Derived Stem Cell treatments. MediVet’s In-Clinic Procedure of isolating Stem Cells from fat tissue and activating that sample prior to administration was independently verified by the University of Kentucky College of Medicine in 2012. This study remains the only independent University analysis of a commercially available system to date. The study concludes that the MediVet system offers the highest in cellular yields to treat and store patients stem cells as well as activation of the sample leads to increases in vital gene expression for repair.
To view this study please visit: Cohen Full Photoactivation Study w/ Donald Cohen, PhD
MediVet Biologics In-Clinic Adipose Derived Stem Cell Technology
Stem Cells from Fat
Isolating a fresh Stem Cells via the Stromal Vascular Fraction
Utilizing Activated Stem Cells via Stromal Vascular Fraction
Improvements in orthopedic conditions
Effect of Adipose Derived Mesenchymal Stem and Regenerative Cells on Lameness in Dogs with Chronic Osteoarthritis of the Coxofemoral Joints: A Randomized, Double Blinded, Multicenter, Controlled Trial.
Utilizing Platelet Rich Plasma with the Sample
MediVet Biologics in-Clinic Platelet Rich Plasma Treatments
Healing ability of Growth Factors
- Platelet-Rich Plasma
- Tendon & Ligament
Avascular Necrosis and Stem Cells Adult Multipotent Stromal Cell Technology for Bone Regeneration Lopez Autologous point of care cellular therapies variably induce equine mesenchymal stem cell migration proliferation and cytokine expression
Cell-based therapies in musculoskeletal injuries the evolving role of bone marrow-derived mesenchymal stem cells Minimal Criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy Position Paper